Skip to main content

Cartesian Therapeutics, Inc.

RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001453687

No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Cartesian Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of RNAC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders8070−10
Shares54.8M54.7M−110.9K (−0.2%)
Value$37.8M$35.3M−$2.50M (−6.6%)

New holders (5)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to RNAC in Q1 2024
InstitutionSharesValue% of portfolio
WR Wealth Planners, LLC1,200$7800.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC16$100.00%
CWM, LLC1$00.00%
Capital Advisors, Ltd. LLC80$00.00%
FNY Investment Advisers, LLC100––

Sold out (15)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of RNAC in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Nantahala Capital Management, LLC2,234,209$1.54M
Madison Avenue Partners, LP582,603$401.6K
Tang Capital Management LLC400,000$275.8K
Ameriprise Financial Inc351,483$242.3K
Gsa Capital Partners LLP134,501$93.0K
Virtu Financial LLC88,683$61.0K
Personal Cfo Solutions, LLC50,888$35.1K
XTX Topco Ltd35,857$24.7K
State Board of Administration of Florida Retirement System30,516$21.0K
Price T Rowe Associates Inc27,039$19.0K
Blair William & Co25,013$17.2K
HighTower Advisors, LLC25,200$17.0K
HRT Financial LP15,053$10.0K
Lazard Asset Management LLC11,143$7.00K
National Bank of Canada1,335$872